Roche Acquires Insulin Patch Pump Maker Medingo For Up To $200 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics is expanding its diabetes care portfolio with the acquisition of Medingo Ltd., maker of the Solo micro insulin patch pump, for up to $200 million
You may also be interested in...
Medtronic Diabetes Pipeline Includes Insulin Patch, Next-Gen CGM
Medtronic is aiming to submit a 510(k) application to FDA for its patch-based insulin delivery device by year-end, setting the stage for a mid-2010 U.S. launch
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.